RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xuebiao Yao to Liver Neoplasms

This is a "connection" page, showing publications Xuebiao Yao has written about Liver Neoplasms.
Connection Strength

0.497
  1. Chen Y, Wang D, Guo Z, Zhao J, Wu B, Deng H, Zhou T, Xiang H, Gao F, Yu X, Liao J, Ward T, Xia P, Emenari C, Ding X, Thompson W, Ma K, Zhu J, Aikhionbare F, Dou K, Cheng SY, Yao X. Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma. Cancer Res. 2011 Mar 01; 71(5):1721-9.
    View in: PubMed
    Score: 0.318
  2. Fang C, Li W, Yin R, Zhu D, Liu X, Wu H, Wang Q, Wang W, Bai Q, Chen B, Yao X, Chen Y. Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway. Sci Rep. 2021 08 13; 11(1):16507.
    View in: PubMed
    Score: 0.164
  3. Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer. 2006 Jun 15; 118(12):2965-72.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support